FNY Investment Advisers’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

FNY Investment Advisers’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$100K	–	899
2023 Q4	$100K	Buy	+10,000	New	+$45.4K	0.11%	132

FNY Investment Advisers's GRCL Position: Q1 2024 in Review

FNY Investment Advisers sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 10,000 shares — an estimated $100K sold.

FNY Investment Advisers first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $100K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

FNY Investment Advisers reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
FNY Investment Advisers sold 10,000 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $100K.
FNY Investment Advisers first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
FNY Investment Advisers's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $100K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on FNY Investment Advisers's 13F filing for Q1 2024, filed 3 May 2024.